Autologous Nanofat Injection Combined with Fractional CO2 Laser in the Treatment of Atrophic Acne Scars
Mahmoud A Rageh,Shady Mahmoud Attia Ibrahim,Noha Abdallah,Abeer Attia Tawfik
DOI: https://doi.org/10.2147/ccid.s454514
2024-03-20
Clinical Cosmetic and Investigational Dermatology
Abstract:Mahmoud A Rageh, 1 Shady Mahmoud Attia Ibrahim, 1 Noha Abdallah, 2 Abeer Attia Tawfik 2 1 Department of Dermatology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt; 2 Department of Medical Applications of Laser, National Institute of Laser Enhanced Sciences, Cairo University, Giza, Egypt Correspondence: Mahmoud A Rageh, Department of Dermatology, Faculty of Medicine, Al-Azhar University, Al-Darrasah, Cairo, 11633, Egypt, Email Background: Atrophic acne scarring is a widely prevalent condition and one of the most distressing complications of acne vulgaris. Numerous options with variable outcomes are available for the treatment of acne scarring. Laser is considered a first‐line therapy for acne scars, and recently there has been a growing interest in using stem cells and their derivatives for treating acne scars. In addition, combined therapeutic modalities often achieve more satisfactory results than a single treatment. Objective: We tried to evaluate the role of nanofat and fractional CO2 laser as a combined treatment approach for atrophic acne scarring. Methods: Twenty-five patients with atrophic acne scarring were enrolled. They received a single session of intradermal nanofat injection, at different points 1 cm apart, for acne scars. Two weeks later, they were treated with three sessions of fractional CO2 laser at monthly intervals. Patients were evaluated three months after the last session using the quantitative Goodman and Baron scoring system. Pain, side effects, and patients' satisfaction were also evaluated. Results: There were two males and 23 females with a mean age of 25.96 years. Their skin type ranged between Fitzpatrick skin type III, IV, and V. Boxcar scars were the most common scar type in 13 patients (52%). After treatment, there was a significant reduction (p < 0.05) in the quantitative Goodman and Baron scores. The improvement was more evident in rolling scars. Seven patients reported significant improvement, and 12 reported marked improvement. Conclusion: This study showed that combining nanofat and fractional CO2 laser is a safe and effective treatment modality for atrophic acne scars. Keywords: acne scars, fractional laser, fat grafting, nanofat Acne vulgaris is a pleomorphic disorder of the pilosebaceous unit. It is the eighth most common disease globally, affecting over 0.5 billion people, and has a prevalence of over 90% in the adolescent community. 1 Acne pathogenesis is attributed to four key factors: excess sebum production, hyperproliferation of Cutibacterium acnes bacteria, hyperkeratinization of the pilosebaceous follicles, and inflammatory mechanisms. 2 Inflammatory acne lesions may result in permanent scars, the severity of which may depend on delays in acne treatment. 3 Atrophic scarring represents about 75% of acne scars and is subdivided into icepick, rolling, and boxcar scars. 4 Acne scars has been found to adversely affect the social life, self-esteem, and body image of affected individuals, and is often co-morbid with psychological disorders including depression and anxiety. 5 Currently, there is no standard treatment for atrophic acne scars. Various treatment approaches have been used to improve the appearance of acne scars, with varying degrees of success. 6 Traditional treatment methods include skin abrasion, chemical peeling, scarring drill excision, tissue filling, microneedling, scarring drill elevation, thread lifting, and photodynamic therapy, while emerging therapies such as mesenchymal stem cells (MSCs) and their derivatives are also available. 7 Laser is a first‐line therapy for acne scars. Fractional CO2 laser improves the appearance of skin by removing portions of the epidermis and dermis as well as heating microthermal zones extending from the epidermis to the mid- or deep dermis. Parts of the epidermis and dermis are replaced by wound-healing responses after the injury, replacing the damaged tissue with healthy, new foci of the epidermis and dermis. 8,9 However, the ensuing downtime, the potential for protracted erythema, and, occasionally, hyperpigmentation constrain fractional CO2 laser. 10 Therefore, through expediting tissue regeneration and wound healing, an adjuvant use of other modalities, such as nanofat, may provide synergistic advantages and reduce side effects. 11 In recent years, many studies have also used stem cells and their derivatives for treating acne scars, among which MSCs and their derivatives are the most commonly used. 7 Nanofat was first described by Tonnard et al in 2013. Its capacity for regeneration is primarily attributable to the a -Abstract Truncated-
dermatology